Post Archive by Month

As the Southern Hemisphere's flu season ends and migrates to the Northern Hemisphere, new data indicates a lull in influenza outbreaks.
In the temperate zones of the Northern Hemisphere, including the United States, indicators of influenza activity were reported at low levels or below the seasonal threshold in most reporting countries.
Published on October 9, 2023, the World Health Organization (WHO)'s Influenza Update N° 455 concluded influenza detections remained low.

Various flu shot benefit analyses are being presented during poster sessions in Boston, Massachusetts, this week. These data highlight the effectiveness and value of influenza vaccination across relevant age groups, risk profiles, and flu seasons with different levels of influenza burden.
An expansive analysis was announced today by CSL Seqirus, offering new data from three studies supporting the clinical, public health, and economic value of both cell-based and adjuvanted seasonal influenza vaccines. 

Now that the U.S. federal government is not distributing COVID-19 vaccines, the Centers for Disease Control and Prevention (CDC) has discontinued issuing new proof of vaccination cards, reported the AP on October 4, 2023.
The federal government shipped more than 980 million vaccination cards between late 2020 through early May 2023, according to the latest available data from the CDC.

One of the challenges in treating Herpes simplex virus (HSV) infections is the diverse nature of clinical manifestations of the disease, wrote the U.S. National Institutes of Health in September 2023.
In many cases, symptomatic infection with HSV can lead to the development of herpetic lesions that present as cold sores or genital herpes, which are familiar sources of disease spread.
HSV infection predominantly occurs through contact with infected tissue of oral or genital mucosal surfaces, shedding the virus.